StockWatch
·

Jubilant Pharmova Ltd Q3 FY25 Results

JUBLPHARMAQ3 FY25 Results
Filing
MetricValue (₹ Cr)vs Q2 FY25
Revenue1.8K4.0%
Total Income1.8K3.2%
Expenditure1.7K4.1%
PBT130.809.5%
Net Profit100.701.8%
OPM-1.39%0.30pp
NPM5.52%0.26pp
EPS6.371.6%
View full financials

Informational and educational content only. Not investment advice.